Demystifying genomics:  Building knowledge for effective cancer care episode artwork

EPISODE · Nov 6, 2024 · 54 MIN

Demystifying genomics: Building knowledge for effective cancer care

from The Cancer Professionals Podcast · host Macmillan Cancer Support

In this episode, we take a deeper look at Genomics with Mary Tanay, Macmillan Nurse Consultant in Genomics and President-Elect of the UK Oncology Nursing Society, alongside Tootie Bueser, Director of Nursing and Midwifery. Together, we explore the increasing role of genetic testing in cancer care, its impact on decision-making, and how genomics can be an integral part of everyday discussions and practice. This episode is produced by The Cancer Professionals Podcast in collaboration with UKONS. This series is brought to you by Macmillan Cancer Support. Links from the episode: Macmillan Genomics Toolkit Genomics Education Programme- NHS EnglandMacmillan Genomics Toolkit: BreastThe National Genomic Test DirectoryNICE (National Institute for Health and Care Excellence) websiteResources to share with the people you supportFind links below to Macmillan's resources about genomics for people affected by cancer:Cancer genomicsDefinitions of key terms:Germline mutation - A gene change in a body's reproductive cell (egg or sperm) that becomes incorporated into the DNA of every cell in the body of the offspring. These gene changes are called germline mutations are passed on from parents to offspring. Also called germline variant.Somatic – Refers to cells and changes within them not related to reproductive cells (egg or sperm), and are not passed to offspring. These changes are called somatic mutations that can occur spontaneously due to due to age and errors in DNA replication or repair, or environmental factors such as UV or chemical exposure. Also called somatic variant.Proband – An individual affected by a genetic condition or who are at risk of a genetic condition. The proband is usually the first affected family member.DPYD – Refers to the gen codes for the enzyme dihydropyridine dehydrogenase crucial for metabolising fluoropyrimidine based chemotherapy drugs like 5-FU. If people have a deficiency they are at higher risk of developing severe side effects so will need treatment adjustments.MMR – Mismatch Repair deficiency is where the MMR proteins are faulty or missing, often associated with Lynch Syndrome and testing can impact on need for screening, earlier diagnosis and treatment decisions.MSI – Microsatellite Instability where there are changes in the length of repetitive DNA sequences called microsatellites. The microsatellite repetitive DNA sequences are found throughout the genome. MSI occurs when the number of repeats in a microsatellite sequence changes due to errors in DNA replication are not corrected by the MMR system. Important in certain cancers like colorectal, endometrial and gastric cancers and often associated with Lynch Syndrome.WGS – Whole Genome Sequencing is a technique that reads the entirety of an individuals DNA sequence and is used to understand an individuals genetic make up and identify genetic variations allowing more accurate diagnosis and treatment. Also supports research to characterise cancers, identify mutations that drive cancer progression to enable development of precision medicine cancer treatments.Please complete this short, anonymous survey to help us understand your experience as a listener- what you find most useful, how you've been able to apply insights from the podcast in your role, and where we can improve. It will only take around 15 minutes to complete: The Cancer Professionals Podcast- listener surveyIf you work in health or social care, visit www.macmillan.org.uk/learning or Macmillan’s Learning Hub for more information about free education and training from Macmillan Cancer Support.Disclaimer: The content and information in these episodes is for informational and educational purposes only and does not constitute medical advice. All examples discussed in episodes are UK based and reflect UK health systems at the time of recording. No material within this series is intended to be a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of your physician or other qualified and registered healthcare providers.

Episode metadata supplied by the publisher feed · Published Nov 6, 2024

Embed this episode

Ready to play

Demystifying genomics: Building knowledge for effective cancer care

0:00 54:07

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Cancer Professionals Podcast?

This episode is 54 minutes long.

When was this The Cancer Professionals Podcast episode published?

This episode was published on November 6, 2024.

Can I download this The Cancer Professionals Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!